10,973 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by Silver Lake Advisory LLC

Silver Lake Advisory LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,973 shares of the pharmacy operator’s stock, valued at approximately $102,000.

A number of other large investors have also recently modified their holdings of the business. First Financial Corp IN raised its stake in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. TD Private Client Wealth LLC grew its stake in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares in the last quarter. Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Eastern Bank bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new position in Walgreens Boots Alliance in the second quarter worth $34,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on WBA. Royal Bank of Canada lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Jefferies Financial Group decreased their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Barclays upped their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $13.27.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $11.74 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $23.76. The business’s 50 day moving average price is $9.73 and its 200-day moving average price is $9.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business posted $0.66 earnings per share. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.